MTOR and nonpapillary renal cell carcinoma: Interestingly, sequence data from 418 ccRCC patients analyzed by the cBIO portal revealed that patients with mTOR mutations exhibited a significant decrease in overall survival (Figure 1c) suggesting that mutations in MTOR have prognostic significance.